Seminars and Presentations

March, 1993: ‘Neurosurgical Approaches to Parkinson’s Disease: Past, Present and Future’, Surgical Grand Rounds, Graduate Hospital, Philadelphia, PA.

February, 1994: ‘Gene Transfer into the CNS with Modified Herpes Vectors’, Wistar Institute, Philadelphia, PA.

April, 1994: ‘Viral Vector Based Gene Delivery into the Brain’, Section on Functional and Stereotactic Surgery, American Association for Neurological Surgeons, San Diego, CA.

April, 1994: ‘Molecular Biology Approaches to Studying Neurological Disorders’ Bockus Research Laboratories, Philadelphia, PA.

December, 1994: ‘Gene Therapy Approaches to CNS Disorders’, START Technology Partnership, Philadelphia, PA.

April, 1994: ‘Prospects for In Vivo Gene Therapy for Parkinson’s Disease’, Sandoz, Inc., (presentation at Graduate Hospital, Philadelphia, PA)

June, 1995: ‘Gene Therapy Approaches to Pituitary Adenomas’; presentation at the International Conference on Gene Therapy for CNS Disorders, Philadelphia, PA.

October, 1995: ‘Gene Transfer into Human Hippocampal Tissue using an Adeno-associated Virus Vector: Prospects for Gene Therapy in Focal Epilepsy’; presentation at The Annual Meeting of the Congress of Neurosurgical Surgeons, San Francisco, CA.

January, 1996: ‘Modulation of Dopamine Systems in the Central Nervous System: Gene Therapy Approaches,’ Institute for Human Gene Therapy, University of Pennsylvania, Genetics Affinity Group, Philadelphia, PA.

January, 1996: ‘Gene Therapy Approaches to Pituitary Adenomas’, the Brain Tumor Group, Wistar Institute, Philadelphia, PA.

March, 1996: ‘Clinical Implications of Genetic Modulation of CNS Dopamine Systems’, First Annual Ernst Freese Memorial Lecture; National Center for Human Genome Research and National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.

April, 1996: ‘Overview of Gene Therapy for Parkinson’s Disease’, The 1st Meeting of the Parkinson’s Disease Gene Therapy Consortium, Washington, D.C.

April, 1996: ‘Clinical Implications of Genetic Modulation of CNS Dopamine Systems’, Neurosurgery Grand Rounds, University of Iowa School of Medicine, Iowa City, IA.

April, 1996: Discussant on ‘Gene Therapy for Brain Tumors by Controlled Expression of Interleukin-lß-Converting Enzyme’, Annual Meeting of the American Association of Neurological Surgeons, Minneapolis, MN.

Pages: 1 2 3 4 5 6

Designed by: Fernandes Tek, LLC